Cargando…
In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy
SIMPLE SUMMARY: Metabolic rewiring, as an important hallmark of cancer supports the bioenergetic needs of growing tumours at the primary site or in metastases. Mammalian target of rapamycin (mTOR) hyperactivity may contribute to metabolic plasticity and progression in cancers. We set out to assess t...
Autores principales: | Petővári, Gábor, Dankó, Titanilla, Tőkés, Anna-Mária, Vetlényi, Enikő, Krencz, Ildikó, Raffay, Regina, Hajdu, Melinda, Sztankovics, Dániel, Németh, Krisztina, Vellai-Takács, Krisztina, Jeney, András, Kulka, Janina, Sebestyén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563878/ https://www.ncbi.nlm.nih.gov/pubmed/32899149 http://dx.doi.org/10.3390/cancers12092492 |
Ejemplares similares
-
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
por: Dankó, Titanilla, et al.
Publicado: (2022) -
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
por: Petővári, Gábor, et al.
Publicado: (2018) -
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
por: Petővári, Gábor, et al.
Publicado: (2019) -
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
por: Krencz, Ildikó, et al.
Publicado: (2022) -
The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues
por: Sebestyén, Anna, et al.
Publicado: (2022)